Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

You are here

Home » Crisantaspase (Erwinase)
Crisantaspase (Erwinase)
Connect with this vendor - Learn about this product
Add to Favourite List
Request Info

Crisantaspase (Erwinase)

GNH India
Category: 
Pharma & Supplements
Drugs

Each ml contains 10,000 Units of Crisantaspase
It is used for Acute lymphoblastic leukemia Treatment (in combination with other chemotherapy) of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase

  • Presentation: Injection
  • Strength:  10,000 Units  
  • Pack Size: 5 Vials.
  • Pack Insert: Yes
  • Marketing Authorization Holder: Porton Biopharma Limited.
  • Manufacturing License: PL 44403/0002
View this product at gnhindia.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree